OnCore Biopharma's Option/Warrant Round

OnCore Biopharma raised a round of funding on September 23, 2014.

OnCore Biopharma is focused on finding a cure for chronic hepatitis B virus infection. The company's mission is to discover and develop an all-oral cure for patients suffering from chronic Hepatitis B…

Articles about OnCore Biopharma's Option/Warrant Round: